Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

RANI THERAPEUTICS HOLDINGS, INC. (RANI) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

RANI THERAPEUTICS HOLDINGS, INC. (RANI), most recent 12 months reported: revenue $4.88M, net loss $30.14M, free cash flow -$20.34M. Latest balance sheet on file: liquid cash $53.39M. From SEC filings. Others in Pharmaceutical Preparations: ROIVANT SCIENCES LTD. · Alumis Inc. · NewAmsterdam Pharma Company N.V. · HCW Biologics Inc. · Bolt Biotherapeutics, Inc. · ENTRADA THERAPEUTICS, INC. · KYNTRA BIO, INC. · Ensysce Biosciences, Inc.

Stock screener

Watchlist